Glyphosate Facts

Transparency on safety aspects and use of glyphosate-containing herbicides in Europe


Webinar: Carcinogenicity of and Epidemiologic research on glyphosate: a look at the evidence

November 8, 4:00 PM – 6:00 PM CET

If you have any questions or comments on the webinar, please do not hesitate to contact us.

In 2015, the International Agency for the Research on Cancer (IARC) categorised the active substance glyphosate as a ‘Category 2A’ probable human carcinogen. Subsequent reviews by regulatory agencies around the world (EFSA, Food and Safety Commission of Japan, US EPA, New Zealand EPA and Australian Pesticides and Veterinary Medicines Authority) and the WHO’s Joint Meeting on Pesticide Residues (JMPR) reaffirmed the prevailing view that glyphosate is not likely to be carcinogenic to humans. IARC appears to stand alone against the other scientific opinions; consumer markets are confused and concerned.

During this webinar Dr. A. Wallace Hayes and Dr. John Acquavella will assess the scientific arguments at hand and will host a scientific discussion on glyphosate and cancer. While Dr. Hayes will primarily focus on the evidence available in an inordinate number of long term toxicology studies with glyphosate, Dr. Acquavella will review the epidemiologic research that pertains to glyphosate.


Speaker biographies:

Dr. John Acquavella is currently Professor at the Department of Clinical Epidemiology at Aarhus University (Denmark). Previously John held the subsequent positions of Executive Director & Oncology Therapeutic Area Head of the Center for Observational Research and Executive Director & Head, Global Epidemiology at Amgen Company. Before Joining Amgen Dr. Acquavella was the Epidemiology Group Lead at Monsanto Company and Exxon Biomedical Sciences respectively.

Dr. Acquavella joined industry after years of experience at University of California as Epidemiology group Lead and at the US Environmental Protection Agency (EPA) as epidemiologist.  He was the recipient of many awards such as the American College of Epidemiology Distinguished Service Award in 2009. He is also a past president of the American College of Epidemiology. Dr. Acquavella holds a B.A. in Psychology from the State University of New York in Buffalo (1976), a M.S. in Epidemiology/ Natural Science of the State University of New York in Buffalo (1977) and a Ph.D. in Epidemiology, Roswell Park Memorial Institute, State University of New York in Buffalo (1989).

Dr. Hayes is a toxicologist with more than 35 years’ experience. He consults for a number of companies and government agencies and holds appointments at Harvard University and University of Massachusetts. Previously, he was Vice President at RJR Nabisco with responsibility for the safety of ingredients worldwide. As Corporate Vice-President at Gillette, he had responsibility for safety and regulatory compliance of consumer products, plant safety, environmental stewardship, and quality control. Dr. Hayes has interacted with regulatory bodies worldwide.

After registering, you will receive a confirmation email containing information about joining the webinar. Please feel free to submit questions in advance of the webinar by responding directly to this email. There will also be an opportunity to submit questions during the webinar itself.

Last update: 16 December 2016